UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000031281
Receipt number R000035704
Scientific Title Open-label clinical study for safety and preliminary efficacy of HiDCV-OS1 Hybrid cell (dendritic and tumor fusion cells) and subsequent subcutaneous administration of GEN0101 in patients with recalcitrant residual or relapsed ovarian cancer after strict chemotherapy.
Date of disclosure of the study information 2018/02/13
Last modified on 2023/08/07 14:48:43

No. Disposal Last modified on Item of update
1 Insert 2018/02/13 17:50:46
2 Update 2018/02/14 18:41:34 Key inclusion criteria
3 Update 2018/05/30 15:20:51 Recruitment status
4 Update 2021/02/17 10:17:05 Recruitment status
Date of IRB
Last follow-up date
5 Update 2023/08/07 13:30:53 Recruitment status
6 Update 2023/08/07 13:43:31 Publication of results
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Plan to share IPD
Plan to share IPD
IPD sharing Plan description
IPD sharing Plan description
7 Update 2023/08/07 14:34:28 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Organization
Address
Address
Tel
Email
8 Update 2023/08/07 14:48:43 Baseline Characteristics